Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PCR-MIBIndependent statistical analysis of Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02662062).
- PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: Complete Statistical AnalysisIndependent statistical analysis of PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PCTDMRTTIndependent statistical analysis of Placebo Controlled Trial of Dextromethorphan in Rett Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01520363).
- PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PDIndependent statistical analysis of Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PDIndependent statistical analysis of Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04928287).
- PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection: Complete Statistical AnalysisIndependent statistical analysis of PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03239899).
- PD0332991Independent statistical analysis of A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma: Complete Statistical AnalysisIndependent statistical analysis of PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01209598).
- PDA+Independent statistical analysis of PDA+: A Personal Digital Assistant for Obesity Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00371462).
- PDC-1421 Treatment in Adult Patients With ADHD: Complete Statistical AnalysisIndependent statistical analysis of PDC-1421 Treatment in Adult Patients With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05202327).
- PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02819440).
- PDIDIndependent statistical analysis of Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PDOP_TLRIndependent statistical analysis of Percutaneous Diskectomy SpineJet x Open Microdiskectomy in Treatment of Lumbar Radiculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PDP1Independent statistical analysis of Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04932434).
- PDPHIndependent statistical analysis of Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PDTIndependent statistical analysis of Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PDT/PDLIndependent statistical analysis of Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05246670).
- PEACE IIIndependent statistical analysis of Positive Psychology to Improve Healthy Behaviors After an Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PEACH2Independent statistical analysis of Promoting Engagement and COVID-19 Testing for Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06141850).
- PEACOCCIndependent statistical analysis of A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Peak Impact Forces and Metabolic Cost During Mid-Forefoot Striking in Shod Versus Barefoot Runners: Complete Statistical AnalysisIndependent statistical analysis of Peak Impact Forces and Metabolic Cost During Mid-Forefoot Striking in Shod Versus Barefoot Runners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors: Complete Statistical AnalysisIndependent statistical analysis of PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors: primary endpoint…
- Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study: Complete Statistical AnalysisIndependent statistical analysis of Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03345160).
- PeanutFlourIndependent statistical analysis of Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02203799).
- PEAR2Independent statistical analysis of Pharmacogenomic Evaluation of Antihypertensive Responses 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01203852).
- PEARL 1Independent statistical analysis of Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size…
- PEARL 3 ExtIndependent statistical analysis of Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PEARL-HFIndependent statistical analysis of Evaluation of Patiromer in Heart Failure Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00868439).
- PEARL-IIndependent statistical analysis of A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection: primary endpoint results,…
- PEARL-IVIndependent statistical analysis of A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PEARLIIIndependent statistical analysis of PGL4001 Versus GnRH-agonist in Uterine Myomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00740831).
- PEARLSIndependent statistical analysis of Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PECEPIndependent statistical analysis of Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PECS II vs. MTP for Analgesia After MRM: Complete Statistical AnalysisIndependent statistical analysis of PECS II vs. MTP for Analgesia After MRM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06187909).
- Pecto-Intercostal Fascial Plane Block Study: Complete Statistical AnalysisIndependent statistical analysis of Pecto-Intercostal Fascial Plane Block Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04928339).
- PEDIndependent statistical analysis of Use of Pedometers to Measure and Increase Walking Among Patients With ESRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PEDALIndependent statistical analysis of Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP): primary endpoint results, effect estimate with confidence…
- Pediatric Aggression and Violence: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Aggression and Violence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01253343).
- Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02713425).
- Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto): Complete Statistical AnalysisIndependent statistical analysis of Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02918773).
- Pediatric Head Lice Study Product Comparison: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Head Lice Study Product Comparison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02213055).
- Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04800094).
- Pediatric Reporting of Adult-Onset Genomic Results: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Reporting of Adult-Onset Genomic Results: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03832985).
- Pediatric Teleneuromodulation: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Teleneuromodulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05071586).
- Pediatric Temperature Variation in the MRI Scanner Under General Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Temperature Variation in the MRI Scanner Under General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01119248).
- Pediatric Tonsillectomy Pain Reduction Study: Complete Statistical AnalysisIndependent statistical analysis of Pediatric Tonsillectomy Pain Reduction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678379).